
19.03.2025 |
Research
A study by Jouko Verho and Jarkko Harju analyzes pharmaceutical pricing in Finland and provides strong evidence of moral hazard behavior in response to government drug price subsidies. The study highlights how copayment thresholds impact prescription drug purchases, offering important insights for healthcare policy.
Read more